Shrinking Fabrication of a Glucose-Responsive Glucagon Microneedle Patch

Area of Science:

• Biomedical Engineering
• Materials Science
• Endocrinology

Background:

• Diabetes management often involves insulin therapy, increasing the risk of hypoglycemia due to overdosage.
• Current microfabrication techniques for biomedical devices face limitations with polymeric materials in aqueous environments, hindering purification.
• Developing safe, non-invasive, and glucose-responsive drug delivery systems is crucial for diabetes treatment.

Purpose of the Study:

• To develop a novel shrinking microfabrication approach for creating biomedical devices with improved purification capabilities.
• To demonstrate the feasibility of this method by fabricating a glucose-responsive transdermal glucagon microneedle patch.
• To evaluate the efficacy and safety of the developed patch in a type 1 diabetic mouse model.

Main Methods:

• Leveraged 3D printing-assisted mold casting for flexible microfabrication.
• Developed a shrinking microfabrication approach enabling post-fabrication washing to remove toxic residues.
• Fabricated a glucose-responsive transdermal glucagon microneedle patch utilizing matrix volume change-mediated release kinetics.

Main Results:

• Successfully developed a glucose-responsive transdermal glucagon microneedle patch using the shrinking microfabrication method.
• Demonstrated the patch's ability to reverse hypoglycemia in a type 1 diabetic mouse model.
• Showcased reduced risk of monomer residue-induced irritation compared to conventional methods.

Conclusions:

• The shrinking microfabrication approach offers a viable alternative for producing purified biomedical devices, overcoming limitations of traditional methods.
• The developed transdermal glucagon microneedle patch provides a safe, effective, and glucose-responsive treatment for hypoglycemia in diabetes.
• This methodology advances post-fabrication purification techniques for biomedical materials and devices.